Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_Cancer_Germline_Mut	i_CGC_Cancer_Molecular_Genetics	i_CGC_Cancer_Somatic_Mut	i_CGC_Cancer_Syndrome	i_CGC_Chr	i_CGC_Chr_Band	i_CGC_GeneID	i_CGC_Name	i_CGC_Other_Germline_Mut	i_CGC_Tissue_Type	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_Ensembl_Gene_ID	i_HGNC_HGNC_ID	i_HGNC_RefSeq_IDs	i_HGNC_Status	i_HGNC_UCSC_ID_supplied_by_UCSC_	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERPplusplus_NR	i_dbNSFP_GERPplusplus_RS	i_dbNSFP_GERPplusplus_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_fold_degenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos_1_coor_	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	i_picard_oxoQ	i_t_ALT_F1R2	i_t_ALT_F2R1	i_t_REF_F1R2	i_t_REF_F2R1	i_t_Foxog	pox	qox	pox_cutoff	isArtifactMode	oxoGCut	i_ffpe_Q	i_ffpe_F	i_ffpe_mode	i_ffpe_p_value	i_ffpe_q_value	i_ffpe_p_value_cutoff	i_ffpe_cut	pon_total_counts_coverage_less_8	pon_total_counts_coverage_greater_8	pon_alt_count_greater1_af_greater_01percent	pon_alt_count_greater2_af_greater_03percent	pon_alt_count_greater3_af_greater_1percent	pon_alt_count_greater3_af_greater_3percent	pon_alt_count_greater3_af_greater_20percent	pon_alt_count_greater10_af_greater_20percent	tumor_only_pon_weight	tumor_only_pass_weight	tumor_only_pass	pon_loglike	pon_weight	pon_pass_grid	pon_pass_loglike	pon_pass_weight	pon_coding	pon_low_alt_count	read_depth	Cosmic(v75) Counts
ERBB2	2064.0	broad.mit.edu	37.0	17	37880257.0	37880257.0	+	Missense_Mutation	SNP	C	C	G			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr17:37880257C>G	ENST00000406381.2	+	21.0	2721.0	c.2211C>G	c.(2209-2211)atC>atG	p.I737M	ERBB2_ENST00000584450.1_Missense_Mutation_p.I767M|ERBB2_ENST00000584601.1_Missense_Mutation_p.I737M|ERBB2_ENST00000445658.2_Missense_Mutation_p.I491M|ERBB2_ENST00000269571.5_Missense_Mutation_p.I767M|ERBB2_ENST00000540147.1_Missense_Mutation_p.I737M|ERBB2_ENST00000541774.1_Missense_Mutation_p.I752M	NM_001005862.1	NP_001005862.1	P04626	ERBB2_HUMAN	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2	767.0	Protein kinase.				cell proliferation|heart development|phosphatidylinositol 3-kinase cascade|phosphatidylinositol-mediated signaling|positive regulation of cell adhesion|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|protein autophosphorylation|regulation of angiogenesis|regulation of microtubule-based process|regulation of transcription, DNA-dependent|transcription, DNA-dependent|wound healing	integral to membrane|nucleus|perinuclear region of cytoplasm|receptor complex	ATP binding|DNA binding|epidermal growth factor receptor activity|ErbB-3 class receptor binding|identical protein binding|protein C-terminus binding|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.I767M(2)		NS(1)|breast(16)|central_nervous_system(17)|endometrium(6)|haematopoietic_and_lymphoid_tissue(8)|kidney(4)|large_intestine(16)|liver(3)|lung(125)|ovary(18)|pancreas(1)|prostate(4)|skin(1)|stomach(14)|upper_aerodigestive_tract(9)|urinary_tract(4)	247.0	all_cancers(6;1.06e-93)|all_epithelial(6;2.33e-113)|Breast(7;9.37e-100)|Lung NSC(9;9.76e-10)|all_lung(9;5.34e-09)|Colorectal(19;0.000442)|Esophageal squamous(10;0.052)	Ovarian(249;0.0547)|Colorectal(1115;0.234)	UCEC - Uterine corpus endometrioid carcinoma (11;0.000126)|Epithelial(3;9.42e-64)|all cancers(3;5.61e-57)|BRCA - Breast invasive adenocarcinoma(8;2.5e-45)|STAD - Stomach adenocarcinoma(3;9.03e-13)|Colorectal(5;6.23e-08)|COAD - Colon adenocarcinoma(5;8.58e-06)|Lung(15;0.00193)|LUAD - Lung adenocarcinoma(14;0.0664)|OV - Ovarian serous cystadenocarcinoma(8;0.0917)|LUSC - Lung squamous cell carcinoma(15;0.171)	UCEC - Uterine corpus endometrioid carcinoma (308;0.0767)	Lapatinib(DB01259)|Letrozole(DB01006)|Trastuzumab(DB00072)	ACAAAGAAATCTTAGACGTAA	0.542		1.0	"""A, Mis, O"""		"""breast, ovarian, other tumour types, NSCLC, gastric"""					TCGA GBM(5;<1E-08)																											Dom	yes		17	17q21.1	2064.0	"""v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)"""		E	2.0	Substitution - Missense(2)	ovary(1)|breast(1)											97.0	85.0	89.0					17																	37880257.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:3430		Approved	uc002hso.3	ENST00000406381.2:c.2211C>G	17.37:g.37880257C>G	ENSP00000385185:p.Ile737Met		B2RZG3|B4DHN3|Q14256|Q6LDV1|Q9UMK4	ENST00000406381.2	37.0	CCDS45667.1	.	.	.	.	.	.	.	.	.	.	C	20.3	3.967983	0.74131	.	.	ENSG00000141736	ENST00000406381;ENST00000541774;ENST00000445658;ENST00000269571;ENST00000540147	D;D;D;D;D	0.82803	-1.65;-1.65;-1.65;-1.65;-1.65	5.02	4.03	0.46877	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	.	.	.	.	T	0.80369	0.4610	N	0.10629	0.01	0.80722	D	1	D;D;D	0.89917	1.0;0.999;1.0	D;D;D	0.87578	0.998;0.998;0.997	T	0.81996	-0.0676	9	0.87932	D	0	.	9.2517	0.37560	0.1439:0.778:0.0:0.0781	.	491;752;767	B4DTR1;P04626-4;P04626	.;.;ERBB2_HUMAN	M	737;752;491;767;737	ENSP00000385185:I737M;ENSP00000446466:I752M;ENSP00000404047:I491M;ENSP00000269571:I767M;ENSP00000443562:I737M	ENSP00000269571:I767M	I	+	3	3	ERBB2	35133783	0.003000	0.15002	0.999000	0.59377	0.961000	0.63080	-0.628000	0.05515	1.082000	0.41137	0.462000	0.41574	ATC	ERBB2-201	KNOWN	basic|CCDS	protein_coding		protein_coding		27.707585	KEEP		+	50.264213	0.126506	21.0	145.0					35.39	11.0	12.0	71.0	103.0	0.521739	0.0	0.0	1.0	0.0	0.0	36.69	0.478261	0.0	0.0	0.0	1.0	0.0	70.0	8054.0	200.0	10.0	0.0	0.0	0.0	0.0	4.478517e-05	0.003	1.0	-20.0	0.9999999	1.0	1.0	1.0	1.0	0.0	166.0	0.0
KMT2A	4297.0	broad.mit.edu	37.0	11	118352546.0	118352546.0	+	Missense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr11:118352546G>A	ENST00000534358.1	+	7.0	3774.0	c.3751G>A	c.(3751-3753)Gat>Aat	p.D1251N	KMT2A_ENST00000389506.5_Missense_Mutation_p.D1251N|KMT2A_ENST00000354520.4_Missense_Mutation_p.D1251N	NM_001197104.1|NM_005933.3	NP_001184033.1|NP_005924.2			lysine (K)-specific methyltransferase 2A																		AGCAAGAGAGGATCCTGCCCC	0.502																																														0.0													107.0	98.0	101.0					11																	118352546.0		2200.0	4296.0	6496.0	SO:0001583	missense			ENSG00000118058	HGNC:7132	NM_005933	Approved		ENST00000534358.1:c.3751G>A	11.37:g.118352546G>A	ENSP00000436786:p.Asp1251Asn			ENST00000534358.1	37.0	CCDS55791.1	.	.	.	.	.	.	.	.	.	.	G	19.22	3.786492	0.70337	.	.	ENSG00000118058	ENST00000534358;ENST00000531904;ENST00000389506;ENST00000354520;ENST00000359313;ENST00000392873	D;T;D;D;D	0.91237	-1.58;0.98;-1.59;-1.55;-2.81	5.67	5.67	0.87782	.	0.296627	0.36303	N	0.002672	D	0.88047	0.6332	L	0.54323	1.7	0.34377	D	0.692738	B;B	0.10296	0.003;0.003	B;B	0.08055	0.003;0.003	D	0.87967	0.2734	10	0.56958	D	0.05	.	13.0426	0.58908	0.0733:0.0:0.9267:0.0	.	1251;1251	E9PQG7;Q03164	.;MLL1_HUMAN	N	1251;1284;1251;1251;161;1	ENSP00000436786:D1251N;ENSP00000432391:D1284N;ENSP00000374157:D1251N;ENSP00000346516:D1251N;ENSP00000376612:D1N	ENSP00000346516:D1251N	D	+	1	0	MLL	117857756	1.000000	0.71417	1.000000	0.80357	0.986000	0.74619	7.489000	0.81451	2.680000	0.91292	0.563000	0.77884	GAT	KMT2A-001	NOVEL	basic|appris_candidate_longest|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000389228.2	14.671464	KEEP		+	93.385867	0.095833	46.0	434.0					35.39	25.0	30.0	237.0	316.0	0.454545	0.0	0.0	1.0	0.0	0.0	36.69	0.545455	1.0	1.07234e-20	1.48379e-20	1.0	0.0	52.0	8087.0	154.0	39.0	0.0	0.0	0.0	0.0	4.042618e-05	0.003	1.0	-20.0	0.9999991	1.0	1.0	1.0	1.0	0.0	480.0	0.0
TP63	8626.0	broad.mit.edu	37.0	3	189604322.0	189604322.0	+	Missense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr3:189604322G>A	ENST00000264731.3	+	11.0	1578.0	c.1489G>A	c.(1489-1491)Gat>Aat	p.D497N	TP63_ENST00000449992.1_Missense_Mutation_p.D318N|TP63_ENST00000440651.2_Missense_Mutation_p.D493N|TP63_ENST00000320472.5_Missense_Mutation_p.D497N|TP63_ENST00000392460.3_Missense_Mutation_p.D497N|TP63_ENST00000392461.3_Missense_Mutation_p.D403N|TP63_ENST00000456148.1_Missense_Mutation_p.D399N|TP63_ENST00000382063.4_Missense_Mutation_p.D412N|TP63_ENST00000354600.5_Missense_Mutation_p.D403N|TP63_ENST00000392463.2_Missense_Mutation_p.D403N	NM_001114978.1|NM_003722.4	NP_001108450.1|NP_003713.3	Q9H3D4	P63_HUMAN	tumor protein p63	497.0					anti-apoptosis|cellular response to UV|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|mitotic cell cycle G1/S transition DNA damage checkpoint|negative regulation of transcription from RNA polymerase II promoter|Notch signaling pathway|positive regulation of Notch signaling pathway|protein homotetramerization|regulation of neuron apoptosis|response to gamma radiation|response to X-ray	chromatin|cytosol|dendrite|Golgi apparatus|transcription factor complex	chromatin binding|damaged DNA binding|double-stranded DNA binding|identical protein binding|metal ion binding|p53 binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity			breast(2)|central_nervous_system(2)|cervix(1)|endometrium(7)|kidney(5)|large_intestine(12)|lung(15)|ovary(2)|skin(9)|upper_aerodigestive_tract(6)	61.0	all_cancers(143;3.35e-10)|Ovarian(172;0.0925)		Lung(62;3.33e-05)	GBM - Glioblastoma multiforme(93;0.0227)		AACCATTCCTGATGGCATGGG	0.512										HNSCC(45;0.13)																																				0.0													103.0	85.0	91.0					3																	189604322.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000073282	HGNC:15979	NM_003722	Approved	uc003fry.2	ENST00000264731.3:c.1489G>A	3.37:g.189604322G>A	ENSP00000264731:p.Asp497Asn		O75080|O75195|O75922|O76078|Q6VEG2|Q6VEG3|Q6VEG4|Q6VFJ1|Q6VFJ2|Q6VFJ3|Q6VH20|Q7LDI3|Q7LDI4|Q7LDI5|Q96KR0|Q9H3D2|Q9H3D3|Q9H3P8|Q9NPH7|Q9P1B4|Q9P1B5|Q9P1B6|Q9P1B7|Q9UBV9|Q9UE10|Q9UP26|Q9UP27|Q9UP28|Q9UP74	ENST00000264731.3	37.0	CCDS3293.1	.	.	.	.	.	.	.	.	.	.	G	17.07	3.294881	0.60086	.	.	ENSG00000073282	ENST00000264731;ENST00000320472;ENST00000392460;ENST00000440651;ENST00000382063;ENST00000354600;ENST00000392463;ENST00000392461;ENST00000449992;ENST00000456148	D;D;D;D;D;D;D;D;D;D	0.99652	-5.97;-6.22;-6.21;-5.97;-6.29;-5.96;-6.2;-6.21;-6.3;-5.96	6.08	6.08	0.98989	.	0.105846	0.64402	D	0.000004	D	0.98413	0.9472	N	0.19112	0.55	0.51767	D	0.999933	B;P;B;B;P;B	0.35033	0.418;0.481;0.228;0.228;0.458;0.294	B;B;B;B;B;B	0.41271	0.32;0.275;0.133;0.173;0.352;0.171	D	0.99509	1.0955	9	.	.	.	-9.9925	19.6603	0.95864	0.0:0.0:1.0:0.0	.	318;497;403;403;497;497	Q9H3D4-10;Q9H3D4-7;Q9H3D4-4;Q9H3D4-2;Q9H3D4-3;Q9H3D4	.;.;.;.;.;P63_HUMAN	N	497;497;497;493;412;403;403;403;318;399	ENSP00000264731:D497N;ENSP00000317510:D497N;ENSP00000376253:D497N;ENSP00000394337:D493N;ENSP00000371495:D412N;ENSP00000346614:D403N;ENSP00000376256:D403N;ENSP00000376254:D403N;ENSP00000387839:D318N;ENSP00000389485:D399N	.	D	+	1	0	TP63	191087016	1.000000	0.71417	0.945000	0.38365	0.988000	0.76386	9.040000	0.93783	2.894000	0.99253	0.591000	0.81541	GAT	TP63-001	KNOWN	basic|CCDS	protein_coding		protein_coding	OTTHUMT00000343865.1	23.932988	KEEP		+	72.013325	0.113497	37.0	289.0					35.39	17.0	22.0	169.0	169.0	0.435897	0.0	0.0	1.0	0.0	0.0	36.69	0.564103	1.0	3.76114e-14	4.71852e-14	1.0	0.0	47.0	7980.0	224.0	69.0	10.0	4.0	0.0	0.0	0.0001639317	0.003	1.0	-3.318698	0.9985055	1.0	1.0	1.0	1.0	0.0	326.0	0.0
ERBB2	2064.0	broad.mit.edu	37.0	17	37864752.0	37864752.0	+	Missense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr17:37864752G>A	ENST00000406381.2	+	5.0	824.0	c.314G>A	c.(313-315)gGa>gAa	p.G105E	ERBB2_ENST00000584450.1_Missense_Mutation_p.G135E|ERBB2_ENST00000584601.1_Missense_Mutation_p.G105E|ERBB2_ENST00000445658.2_Intron|ERBB2_ENST00000269571.5_Missense_Mutation_p.G135E|ERBB2_ENST00000540147.1_Missense_Mutation_p.G105E|ERBB2_ENST00000578199.1_Missense_Mutation_p.G105E|ERBB2_ENST00000541774.1_Missense_Mutation_p.G120E|ERBB2_ENST00000540042.1_Missense_Mutation_p.G105E	NM_001005862.1	NP_001005862.1	P04626	ERBB2_HUMAN	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2	135.0					cell proliferation|heart development|phosphatidylinositol 3-kinase cascade|phosphatidylinositol-mediated signaling|positive regulation of cell adhesion|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|protein autophosphorylation|regulation of angiogenesis|regulation of microtubule-based process|regulation of transcription, DNA-dependent|transcription, DNA-dependent|wound healing	integral to membrane|nucleus|perinuclear region of cytoplasm|receptor complex	ATP binding|DNA binding|epidermal growth factor receptor activity|ErbB-3 class receptor binding|identical protein binding|protein C-terminus binding|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(1)|breast(16)|central_nervous_system(17)|endometrium(6)|haematopoietic_and_lymphoid_tissue(8)|kidney(4)|large_intestine(16)|liver(3)|lung(125)|ovary(18)|pancreas(1)|prostate(4)|skin(1)|stomach(14)|upper_aerodigestive_tract(9)|urinary_tract(4)	247.0	all_cancers(6;1.06e-93)|all_epithelial(6;2.33e-113)|Breast(7;9.37e-100)|Lung NSC(9;9.76e-10)|all_lung(9;5.34e-09)|Colorectal(19;0.000442)|Esophageal squamous(10;0.052)	Ovarian(249;0.0547)|Colorectal(1115;0.234)	UCEC - Uterine corpus endometrioid carcinoma (11;0.000126)|Epithelial(3;9.42e-64)|all cancers(3;5.61e-57)|BRCA - Breast invasive adenocarcinoma(8;2.5e-45)|STAD - Stomach adenocarcinoma(3;9.03e-13)|Colorectal(5;6.23e-08)|COAD - Colon adenocarcinoma(5;8.58e-06)|Lung(15;0.00193)|LUAD - Lung adenocarcinoma(14;0.0664)|OV - Ovarian serous cystadenocarcinoma(8;0.0917)|LUSC - Lung squamous cell carcinoma(15;0.171)	UCEC - Uterine corpus endometrioid carcinoma (308;0.0767)	Lapatinib(DB01259)|Letrozole(DB01006)|Trastuzumab(DB00072)	GCCTCCCCAGGAGGCCTGCGG	0.592		1.0	"""A, Mis, O"""		"""breast, ovarian, other tumour types, NSCLC, gastric"""					TCGA GBM(5;<1E-08)																											Dom	yes		17	17q21.1	2064.0	"""v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)"""		E	0.0													63.0	71.0	68.0					17																	37864752.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:3430		Approved	uc002hso.3	ENST00000406381.2:c.314G>A	17.37:g.37864752G>A	ENSP00000385185:p.Gly105Glu		B2RZG3|B4DHN3|Q14256|Q6LDV1|Q9UMK4	ENST00000406381.2	37.0	CCDS45667.1	.	.	.	.	.	.	.	.	.	.	G	9.817	1.184826	0.21870	.	.	ENSG00000141736	ENST00000406381;ENST00000541774;ENST00000269571;ENST00000540147;ENST00000540042	T;T;T;T;T	0.80214	-0.81;-0.82;-0.82;-0.81;-1.35	4.65	0.271	0.15640	EGF receptor, L domain (1);	.	.	.	.	T	0.49847	0.1581	N	0.04508	-0.205	0.09310	N	1	B;B;B;B	0.18461	0.001;0.001;0.0;0.028	B;B;B;B	0.15484	0.003;0.003;0.007;0.013	T	0.39663	-0.9603	9	0.06757	T	0.87	.	1.1573	0.01799	0.3802:0.1444:0.328:0.1474	.	105;120;135;135	F5H1T4;P04626-4;P04626;Q9UK79	.;.;ERBB2_HUMAN;.	E	105;120;135;105;105	ENSP00000385185:G105E;ENSP00000446466:G120E;ENSP00000269571:G135E;ENSP00000443562:G105E;ENSP00000446382:G105E	ENSP00000269571:G135E	G	+	2	0	ERBB2	35118278	0.000000	0.05858	0.470000	0.27216	0.907000	0.53573	-1.144000	0.03197	0.101000	0.17610	-0.367000	0.07326	GGA	ERBB2-201	KNOWN	basic|CCDS	protein_coding		protein_coding		-7.432149	KEEP		+	39.693083	0.080153	21.0	241.0					35.39	17.0	10.0	142.0	143.0	0.62963	0.0	0.0	1.0	0.0	0.0	36.69	0.37037	1.0	9.86323e-18	1.31045e-17	1.0	0.0	57.0	8153.0	77.0	43.0	0.0	0.0	0.0	0.0	2.510912e-05	0.003	1.0	-20.0	1.0	1.0	1.0	1.0	1.0	0.0	262.0	0.0
PIK3R2	5296.0	broad.mit.edu	37.0	19	18279552.0	18279552.0	+	Missense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr19:18279552G>A	ENST00000593731.1	+	15.0	2385.0	c.1825G>A	c.(1825-1827)Gag>Aag	p.E609K	PIK3R2_ENST00000222254.8_Missense_Mutation_p.E609K			O00459	P85B_HUMAN	phosphoinositide-3-kinase, regulatory subunit 2 (beta)	609.0					fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|negative regulation of anti-apoptosis|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction|T cell costimulation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	GTPase activator activity|phosphatidylinositol 3-kinase regulator activity|protein binding			endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(12)|ovary(3)|pancreas(1)|stomach(1)	24.0						CGCACTCATGGAGGACGAGGA	0.657											OREG0025359	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)																																		0.0													45.0	33.0	37.0					19																	18279552.0		2202.0	4300.0	6502.0	SO:0001583	missense			ENSG00000105647	HGNC:8980	NM_005027	Approved	uc002nia.2	ENST00000593731.1:c.1825G>A	19.37:g.18279552G>A	ENSP00000471914:p.Glu609Lys	724.0	Q5EAT5|Q9UPH9	ENST00000593731.1	37.0	CCDS12371.1	.	.	.	.	.	.	.	.	.	.	G	14.71	2.615863	0.46631	.	.	ENSG00000105647	ENST00000222254	T	0.50548	0.74	3.83	3.83	0.44106	.	0.211900	0.39834	N	0.001256	T	0.35998	0.0951	L	0.37561	1.115	0.51233	D	0.99991	B	0.20368	0.044	B	0.13407	0.009	T	0.32903	-0.9889	10	0.66056	D	0.02	-30.022	9.5001	0.39013	0.1024:0.0:0.8976:0.0	.	609	O00459	P85B_HUMAN	K	609	ENSP00000222254:E609K	ENSP00000222254:E609K	E	+	1	0	PIK3R2	18140552	1.000000	0.71417	1.000000	0.80357	0.163000	0.22366	7.724000	0.84798	2.091000	0.63221	0.313000	0.20887	GAG	PIK3R2-001	KNOWN	basic|appris_principal|readthrough_transcript|CCDS	nonsense_mediated_decay		protein_coding	OTTHUMT00000466386.2	-8.098397	KEEP		+	15.80469	0.065574	8.0	114.0					35.39	5.0	3.0	58.0	64.0	0.625	0.0	0.0	1.0	0.0	0.0	36.69	0.375	1.0	5.18039e-06	5.60262e-06	1.0	0.0	639.0	7475.0	191.0	23.0	4.0	0.0	0.0	0.0	7.227537e-05	0.003	1.0	-5.234942	0.9999859	1.0	1.0	1.0	1.0	0.0	122.0	0.0
PIK3CB	5291.0	broad.mit.edu	37.0	3	138433351.0	138433351.0	+	Missense_Mutation	SNP	T	T	G			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr3:138433351T>G	ENST00000477593.1	-	8.0	1334.0	c.1261A>C	c.(1261-1263)Aat>Cat	p.N421H	PIK3CB_ENST00000289153.2_Missense_Mutation_p.N421H			P42338	PK3CB_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	421.0	C2 PI3K-type.				activation of MAPK activity|chemotaxis|fibroblast growth factor receptor signaling pathway|G-protein coupled receptor protein signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity			NS(1)|breast(3)|endometrium(5)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(4)	41.0						TTAGAGGGATTAATAGTTTTC	0.308																																														0.0													140.0	133.0	135.0					3																	138433351.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000051382	HGNC:8976		Approved	uc011bmq.3	ENST00000477593.1:c.1261A>C	3.37:g.138433351T>G	ENSP00000418143:p.Asn421His		D3DNF0|Q24JU2	ENST00000477593.1	37.0	CCDS3104.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	T|T	14.21|14.21	2.466249|2.466249	0.43839|0.43839	.|.	.|.	ENSG00000051382|ENSG00000051382	ENST00000493568|ENST00000477593;ENST00000289153	.|T;T	.|0.70516	.|-0.49;-0.49	5.46|5.46	5.46|5.46	0.80206|0.80206	.|C2 calcium/lipid-binding domain, CaLB (1);Phosphoinositide 3-kinase, C2 (2);	.|0.554996	.|0.19124	.|N	.|0.122100	T|T	0.47002|0.47002	0.1422|0.1422	N|N	0.02011|0.02011	-0.69|-0.69	0.80722|0.80722	D|D	1|1	.|B;B	.|0.12630	.|0.004;0.006	.|B;B	.|0.13407	.|0.009;0.007	T|T	0.46693|0.46693	-0.9173|-0.9173	5|10	.|0.45353	.|T	.|0.12	-15.5739|-15.5739	14.3971|14.3971	0.67018|0.67018	0.0:0.0:0.0:1.0|0.0:0.0:0.0:1.0	.|.	.|421;25	.|P42338;B4DZI3	.|PK3CB_HUMAN;.	F|H	69|421	.|ENSP00000418143:N421H;ENSP00000289153:N421H	.|ENSP00000289153:N421H	L|N	-|-	3|1	2|0	PIK3CB|PIK3CB	139916041|139916041	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.997000|0.997000	0.91878|0.91878	3.738000|3.738000	0.55067|0.55067	2.189000|2.189000	0.69895|0.69895	0.528000|0.528000	0.53228|0.53228	TTA|AAT	PIK3CB-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000358019.1	-40.473705	KEEP		-	8.498477	0.051948	12.0	219.0					35.39	0.0	12.0	95.0	136.0	0.0	0.0	0.0	1.0	0.0	0.0	36.69		0.0	0.0	0.0	1.0	0.0	48.0	8185.0	85.0	12.0	4.0	0.0	0.0	0.0	4.831236e-05	0.003	1.0	-4.93796	1.0	1.0	1.0	1.0	1.0	0.0	231.0	0.0
KMT2C	58508.0	broad.mit.edu	37.0	7	152009027.0	152009027.0	+	Nonsense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr7:152009027G>A	ENST00000355193.2	-	5.0	813.0	c.595C>T	c.(595-597)Cga>Tga	p.R199*	KMT2C_ENST00000262189.6_Nonsense_Mutation_p.R199*					lysine (K)-specific methyltransferase 2C									p.R199*(2)									TGAGGAGATCGTTCTCTGAAA	0.348																																														2.0	Substitution - Nonsense(2)	lung(2)											81.0	80.0	80.0					7																	152009027.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.595C>T	7.37:g.152009027G>A	ENSP00000347325:p.Arg199*			ENST00000355193.2	37.0		.	.	.	.	.	.	.	.	.	.	G	38	7.267330	0.98175	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	.	.	.	5.61	4.67	0.58626	.	0.197931	0.24267	N	0.040024	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.05959	T	0.93	.	11.7717	0.51962	0.0:0.0:0.6917:0.3083	.	.	.	.	X	199	.	ENSP00000262189:R199X	R	-	1	2	MLL3	151639960	1.000000	0.71417	0.999000	0.59377	0.997000	0.91878	2.666000	0.46799	2.820000	0.97059	0.650000	0.86243	CGA	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		11.158309	KEEP		-	52.982346	0.099617	26.0	235.0					35.39	8.0	18.0	110.0	143.0	0.307692	0.0	0.0	1.0	0.0	0.0	36.69	0.692308	1.0	5.35047e-06	5.78052e-06	1.0	0.0	46.0	7846.0	357.0	78.0	0.0	4.0	0.0	0.0	0.0001205819	0.003	1.0	-3.318693	0.9965486	1.0	1.0	1.0	1.0	0.0	261.0	2.0
KMT2D	8085.0	broad.mit.edu	37.0	12	49416417.0	49416417.0	+	Missense_Mutation	SNP	G	G	A			AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr12:49416417G>A	ENST00000301067.7	-	51.0	16293.0	c.16294C>T	c.(16294-16296)Cgg>Tgg	p.R5432W		NM_003482.3	NP_003473.3			lysine (K)-specific methyltransferase 2D									p.R5432W(1)|p.R5162W(1)									ACCTCGTTCCGAATGATGGTG	0.557																																														2.0	Substitution - Missense(2)	haematopoietic_and_lymphoid_tissue(2)											188.0	192.0	190.0					12																	49416417.0		2019.0	4162.0	6181.0	SO:0001583	missense			ENSG00000167548	HGNC:7133		Approved		ENST00000301067.7:c.16294C>T	12.37:g.49416417G>A	ENSP00000301067:p.Arg5432Trp			ENST00000301067.7	37.0	CCDS44873.1	.	.	.	.	.	.	.	.	.	.	G	13.15	2.152122	0.38021	.	.	ENSG00000167548	ENST00000301067;ENST00000526209	D;D	0.81821	-1.54;-1.54	5.09	5.09	0.68999	SET domain (3);	0.000000	0.37304	N	0.002155	D	0.92642	0.7662	H	0.96970	3.915	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	D	0.94286	0.7524	10	0.87932	D	0	.	12.7164	0.57117	0.0:0.0:0.8351:0.1649	.	5432	O14686	MLL2_HUMAN	W	5432;113	ENSP00000301067:R5432W;ENSP00000435714:R113W	ENSP00000301067:R5432W	R	-	1	2	MLL2	47702684	1.000000	0.71417	1.000000	0.80357	0.953000	0.61014	7.767000	0.85331	2.546000	0.85860	0.591000	0.81541	CGG	KMT2D-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000390183.2	23.259776	KEEP		-	43.386617	0.127517	19.0	130.0					35.39	10.0	11.0	49.0	89.0	0.47619	0.0	0.0	1.0	0.0	0.0	36.69	0.52381	1.0	2.4624e-09	2.80681e-09	1.0	0.0	91.0	8073.0	74.0	31.0	61.0	4.0	0.0	0.0	0.000492804	0.003	1.0	-3.324263	0.9905925	1.0	1.0	1.0	1.0	0.0	149.0	0.0
EP300	2033.0	broad.mit.edu	37.0	22	41566520.0	41566520.0	+	Missense_Mutation	SNP	G	G	T			AC-P04-Tumor-SM-63B4Q	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P04-Tumor-SM-63B4Q	none	g.chr22:41566520G>T	ENST00000263253.7	+	27.0	5616.0	c.4397G>T	c.(4396-4398)tGg>tTg	p.W1466L	RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	1466.0					apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						CTGCAGGAATGGTACAAAAAA	0.478			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22.0	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	0.0													127.0	109.0	115.0					22																	41566520.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.4397G>T	22.37:g.41566520G>T	ENSP00000263253:p.Trp1466Leu		B1AKC2	ENST00000263253.7	37.0	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	G	21.8	4.207837	0.79240	.	.	ENSG00000100393	ENST00000263253	D	0.99745	-6.61	5.5	4.46	0.54185	.	0.000000	0.43260	D	0.000597	D	0.99527	0.9831	H	0.96720	3.87	0.54753	D	0.999982	B	0.12630	0.006	B	0.17098	0.017	D	0.98633	1.0672	10	0.87932	D	0	-4.1369	15.4345	0.75133	0.0:0.0:0.86:0.14	.	1466	Q09472	EP300_HUMAN	L	1466	ENSP00000263253:W1466L	ENSP00000263253:W1466L	W	+	2	0	EP300	39896466	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	9.760000	0.98935	1.273000	0.44346	0.655000	0.94253	TGG	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	56.708569	KEEP		+	57.114636	0.403846	21.0	31.0					53.38	11.0	12.0	14.0	21.0	0.478261	1.50039e-11	1.67356e-11	1.0	1.0	0.0	29.85	0.521739	0.0	0.0	0.0	0.062417	0.0	47.0	7841.0	310.0	103.0	14.0	19.0	0.0	0.0	0.0003620099	0.003	1.0	-6.187072	0.9892544	1.0	1.0	1.0	1.0	0.0	52.0	3.0
FBXW7	0.0	broad.mit.edu	37.0	4	153250883.0	153250883.0	+	Nonsense_Mutation	SNP	G	G	A			AC-P04-Tumor-SM-63B4Q	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P04-Tumor-SM-63B4Q	none	g.chr4:153250883G>A	ENST00000281708.4	-	8.0	2406.0	c.1177C>T	c.(1177-1179)Cga>Tga	p.R393*	FBXW7_ENST00000296555.5_Nonsense_Mutation_p.R275*|FBXW7_ENST00000603548.1_Nonsense_Mutation_p.R393*|FBXW7_ENST00000263981.5_Nonsense_Mutation_p.R313*|FBXW7_ENST00000603841.1_Nonsense_Mutation_p.R393*|FBXW7_ENST00000393956.3_Nonsense_Mutation_p.R217*	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	393.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R393*(7)|p.R313*(1)|p.R154*(1)|p.?(1)|p.R275*(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				CTAACTATTCGGTTACCACAA	0.343			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	11.0	Substitution - Nonsense(10)|Unknown(1)	endometrium(5)|large_intestine(4)|haematopoietic_and_lymphoid_tissue(1)|stomach(1)											118.0	107.0	111.0					4																	153250883.0		2203.0	4300.0	6503.0	SO:0001587	stop_gained				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1177C>T	4.37:g.153250883G>A	ENSP00000281708:p.Arg393*		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	20.3	3.966716	0.74131	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	.	.	.	5.99	4.05	0.47172	.	0.053576	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-12.7554	12.3616	0.55207	0.0:0.0953:0.6907:0.214	.	.	.	.	X	393;275;313;217	.	ENSP00000263981:R313X	R	-	1	2	FBXW7	153470333	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	5.416000	0.66417	1.513000	0.48852	0.650000	0.86243	CGA	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	220.136181	KEEP		-	220.672102	0.568182	75.0	57.0					53.38	42.0	53.0	27.0	47.0	0.442105	0.0	0.0	1.0	0.0	0.0	29.85	0.557895	1.0	4.02937e-33	5.97295e-33	0.048971	0.0	46.0	7917.0	191.0	124.0	35.0	21.0	0.0	0.0	0.0005234686	0.003	1.0	-19.99941	0.9868633	1.0	1.0	1.0	1.0	0.0	132.0	6.0
FBXW7	0.0	broad.mit.edu	37.0	4	153250884.0	153250884.0	+	Missense_Mutation	SNP	G	G	T			AC-P04-Tumor-SM-63B4Q	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P04-Tumor-SM-63B4Q	none	g.chr4:153250884G>T	ENST00000281708.4	-	8.0	2405.0	c.1176C>A	c.(1174-1176)aaC>aaA	p.N392K	FBXW7_ENST00000296555.5_Missense_Mutation_p.N274K|FBXW7_ENST00000603548.1_Missense_Mutation_p.N392K|FBXW7_ENST00000263981.5_Missense_Mutation_p.N312K|FBXW7_ENST00000603841.1_Missense_Mutation_p.N392K|FBXW7_ENST00000393956.3_Missense_Mutation_p.N216K	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	392.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TAACTATTCGGTTACCACAAA	0.338			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	1.0	Unknown(1)	haematopoietic_and_lymphoid_tissue(1)											117.0	107.0	111.0					4																	153250884.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1176C>A	4.37:g.153250884G>T	ENSP00000281708:p.Asn392Lys		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	16.03	3.007577	0.54361	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.60920	0.15;0.15;0.15;0.15	5.99	5.99	0.97316	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.038091	0.85682	D	0.000000	T	0.50735	0.1633	N	0.20881	0.62	0.80722	D	1	P;P;P;P	0.48350	0.909;0.869;0.889;0.818	B;B;B;B	0.44044	0.308;0.439;0.205;0.205	T	0.43327	-0.9398	10	0.30854	T	0.27	-21.0164	20.5373	0.99239	0.0:0.0:1.0:0.0	.	216;392;274;312	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	K	392;274;312;216	ENSP00000281708:N392K;ENSP00000296555:N274K;ENSP00000263981:N312K;ENSP00000377528:N216K	ENSP00000263981:N312K	N	-	3	2	FBXW7	153470334	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	5.705000	0.68355	2.857000	0.98124	0.650000	0.86243	AAC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	224.077556	KEEP		-	224.836249	0.580153	76.0	55.0					53.38	41.0	54.0	26.0	45.0	0.431579	8.40228e-50	9.76683e-50	1.0	1.0	0.0	29.85	0.568421	0.0	0.0	0.0	0.048971	0.0	48.0	8108.0	128.0	44.0	5.0	0.0	0.0	0.0	8.892958e-05	0.003	1.0	-20.0	0.9999999	1.0	1.0	1.0	1.0	0.0	131.0	0.0
PIK3CA	5290.0	broad.mit.edu	37.0	3	178936082.0	178936082.0	+	Missense_Mutation	SNP	G	G	A	rs121913273		AC-P06-Tumor-SM-63B4T	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P06-Tumor-SM-63B4T	none	g.chr3:178936082G>A	ENST00000263967.3	+	10.0	1781.0	c.1624G>A	c.(1624-1626)Gaa>Aaa	p.E542K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	542.0	PI3K helical.		E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation).|E -> Q (in cancer).|E -> V (in cancer).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E542K(545)|p.E542Q(10)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TCCTCTCTCTGAAATCACTGA	0.333	E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT)	57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3.0	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	555.0	Substitution - Missense(555)	breast(176)|large_intestine(166)|urinary_tract(45)|endometrium(37)|skin(19)|lung(18)|stomach(16)|ovary(16)|thyroid(14)|upper_aerodigestive_tract(9)|central_nervous_system(7)|cervix(6)|liver(6)|oesophagus(5)|penis(4)|kidney(3)|soft_tissue(2)|haematopoietic_and_lymphoid_tissue(2)|prostate(2)|biliary_tract(1)|pituitary(1)											56.0	56.0	56.0					3																	178936082.0		1809.0	4069.0	5878.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1624G>A	3.37:g.178936082G>A	ENSP00000263967:p.Glu542Lys		Q14CW1|Q99762	ENST00000263967.3	37.0	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	34	5.360420	0.95877	.	.	ENSG00000121879	ENST00000263967	T	0.62105	0.05	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.69287	0.3094	L	0.41356	1.27	0.80722	D	1	D	0.65815	0.995	D	0.63192	0.912	T	0.60296	-0.7291	10	0.09843	T	0.71	-23.9623	20.0024	0.97423	0.0:0.0:1.0:0.0	.	542	P42336	PK3CA_HUMAN	K	542	ENSP00000263967:E542K	ENSP00000263967:E542K	E	+	1	0	PIK3CA	180418776	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAA	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	38.249853	KEEP		+	39.766179	0.320755	17.0	36.0					33.81	11.0	10.0	20.0	29.0	0.52381	0.0	0.0	1.0	0.0	0.0	31.17	0.47619	1.0	1.01871e-10	1.30786e-10	1.0	0.0	107.0	7922.0	236.0	53.0	8.0	7.0	0.0	0.0	0.0001847345	0.003	1.0	-4.901175	0.9996784	1.0	1.0	1.0	1.0	0.0	53.0	280.0
EP300	2033.0	broad.mit.edu	37.0	22	41566429.0	41566429.0	+	Missense_Mutation	SNP	T	T	C			AC-P07-Tumor-SM-63B4V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P07-Tumor-SM-63B4V	none	g.chr22:41566429T>C	ENST00000263253.7	+	27.0	5525.0	c.4306T>C	c.(4306-4308)Tgg>Cgg	p.W1436R	RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	1436.0					apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						AGGGCATATTTGGGCATGTCC	0.403			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22.0	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	0.0													129.0	115.0	120.0					22																	41566429.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.4306T>C	22.37:g.41566429T>C	ENSP00000263253:p.Trp1436Arg		B1AKC2	ENST00000263253.7	37.0	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	T	18.55	3.647337	0.67358	.	.	ENSG00000100393	ENST00000263253	D	0.94232	-3.38	5.31	5.31	0.75309	.	0.000000	0.44285	D	0.000463	D	0.97873	0.9301	H	0.96691	3.865	0.58432	D	0.999992	D	0.76494	0.999	D	0.91635	0.999	D	0.99331	1.0909	10	0.87932	D	0	-3.6988	15.2851	0.73822	0.0:0.0:0.0:1.0	.	1436	Q09472	EP300_HUMAN	R	1436	ENSP00000263253:W1436R	ENSP00000263253:W1436R	W	+	1	0	EP300	39896375	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.953000	0.87836	2.004000	0.58718	0.533000	0.62120	TGG	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	81.196138	KEEP		+	85.071483	0.295238	31.0	74.0					49.34	17.0	21.0	44.0	44.0	0.447368	0.0	0.0	1.0	0.0	0.0	30.02		0.0	0.0	0.0	1.0	0.0	47.0	8166.0	94.0	23.0	0.0	0.0	0.0	0.0	2.865457e-05	0.003	1.0	-20.0	1.0	1.0	1.0	1.0	1.0	0.0	105.0	0.0
KMT2C	58508.0	broad.mit.edu	37.0	7	151970910.0	151970910.0	+	Missense_Mutation	SNP	A	A	C			AC-P07-Tumor-SM-63B4V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P07-Tumor-SM-63B4V	none	g.chr7:151970910A>C	ENST00000355193.2	-	7.0	1110.0	c.892T>G	c.(892-894)Tgt>Ggt	p.C298G	KMT2C_ENST00000262189.6_Missense_Mutation_p.C298G					lysine (K)-specific methyltransferase 2C																		TTCTCTTCACAGCATTTGATA	0.413																																														0.0													103.0	100.0	101.0					7																	151970910.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000055609	HGNC:13726		Approved		ENST00000355193.2:c.892T>G	7.37:g.151970910A>C	ENSP00000347325:p.Cys298Gly			ENST00000355193.2	37.0		.	.	.	.	.	.	.	.	.	.	A	16.50	3.141927	0.57044	.	.	ENSG00000055609	ENST00000262189;ENST00000355193	T;T	0.70516	-0.49;-0.49	4.87	4.87	0.63330	Zinc finger, PHD-type (1);	0.000000	0.48767	D	0.000161	T	0.80232	0.4585	L	0.58810	1.83	0.80722	D	1	D	0.76494	0.999	D	0.85130	0.997	T	0.77579	-0.2535	10	0.25751	T	0.34	.	14.77	0.69668	1.0:0.0:0.0:0.0	.	298	Q8NEZ4	MLL3_HUMAN	G	298	ENSP00000262189:C298G;ENSP00000347325:C298G	ENSP00000262189:C298G	C	-	1	0	MLL3	151601843	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	9.257000	0.95545	1.962000	0.57031	0.528000	0.53228	TGT	KMT2C-201	KNOWN	basic|appris_candidate_longest	protein_coding		protein_coding		-13.160278	KEEP		-	24.520354	0.06701	13.0	181.0					49.34	5.0	14.0	120.0	141.0	0.736842	0.0	0.0	1.0	0.0	0.0	30.02		0.0	0.0	0.0	1.0	0.0	48.0	8267.0	8.0	8.0	0.0	0.0	0.0	0.0	3.357117e-06	0.003	1.0	-17.64359	1.0	1.0	1.0	1.0	1.0	0.0	194.0	0.0
TP53	7157.0	broad.mit.edu	37.0	17	7577543.0	7577543.0	+	Missense_Mutation	SNP	C	C	T			AC-P07-Tumor-SM-63B4V	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P07-Tumor-SM-63B4V	none	g.chr17:7577543C>T	ENST00000420246.2	-	7.0	870.0	c.738G>A	c.(736-738)atG>atA	p.M246I	TP53_ENST00000413465.2_Missense_Mutation_p.M246I|TP53_ENST00000269305.4_Missense_Mutation_p.M246I|TP53_ENST00000359597.4_Missense_Mutation_p.M246I|TP53_ENST00000455263.2_Missense_Mutation_p.M246I|TP53_ENST00000445888.2_Missense_Mutation_p.M246I	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	246.0	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain.		M -> I (in sporadic cancers; somatic mutation).|M -> K (in sporadic cancers; somatic mutation).|M -> L (in sporadic cancers; somatic mutation).|M -> R (in sporadic cancers; somatic mutation).|M -> T (in sporadic cancers; somatic mutation).|M -> V (in LFS; germline mutation and in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.M246I(24)|p.0?(8)|p.?(5)|p.M246_P250delMNRRP(2)|p.C242fs*98(1)|p.C238_M246delCNSSCMGGM(1)|p.G245fs*14(1)|p.G245fs*16(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185.0		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GCCTCCGGTTCATGCCGCCCA	0.572		111.0	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																									Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17.0	17p13	7157.0	tumor protein p53		"""L, E, M, O"""	43.0	Substitution - Missense(24)|Whole gene deletion(8)|Unknown(5)|Deletion - In frame(3)|Deletion - Frameshift(3)	upper_aerodigestive_tract(8)|biliary_tract(5)|ovary(5)|central_nervous_system(4)|bone(4)|large_intestine(3)|stomach(3)|breast(3)|haematopoietic_and_lymphoid_tissue(2)|urinary_tract(2)|liver(1)|lung(1)|skin(1)|pancreas(1)											152.0	113.0	126.0					17																	7577543.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	ENST00000420246.2:c.738G>A	17.37:g.7577543C>T	ENSP00000391127:p.Met246Ile		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37.0	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	25.7	4.664920	0.88251	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944	D;D;D;D;D;D;D;D	0.99789	-6.75;-6.75;-6.75;-6.75;-6.75;-6.75;-6.75;-6.75	4.62	4.62	0.57501	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99468	0.9811	L	0.33624	1.015	0.80722	D	1	P;B;B;D;P;D	0.76494	0.895;0.098;0.057;0.969;0.474;0.999	D;B;B;D;P;D	0.83275	0.931;0.24;0.082;0.959;0.865;0.996	D	0.97709	1.0189	10	0.87932	D	0	-28.5667	15.3618	0.74483	0.0:1.0:0.0:0.0	.	246;246;153;246;246;246	P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;P53_HUMAN;.;.	I	246;246;246;246;246;246;235;153;114;153	ENSP00000410739:M246I;ENSP00000352610:M246I;ENSP00000269305:M246I;ENSP00000398846:M246I;ENSP00000391127:M246I;ENSP00000391478:M246I;ENSP00000425104:M114I;ENSP00000423862:M153I	ENSP00000269305:M246I	M	-	3	0	TP53	7518268	1.000000	0.71417	1.000000	0.80357	0.957000	0.61999	7.609000	0.82925	2.564000	0.86499	0.462000	0.41574	ATG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding		protein_coding	OTTHUMT00000367401.1	38.675878	KEEP		-	43.36065	0.24359	19.0	59.0					49.34	10.0	11.0	25.0	50.0	0.52381	0.0	0.0	1.0	0.0	0.0	30.02	0.47619	1.0	1.01871e-10	1.31724e-10	1.0	0.0	33.0	8028.0	192.0	74.0	0.0	5.0	0.0	0.0	0.000100259	0.003	1.0	-4.047923	0.9998754	1.0	1.0	1.0	1.0	0.0	78.0	4.0
PTEN	5728.0	broad.mit.edu	37.0	10	89692905.0	89692905.0	+	Missense_Mutation	SNP	G	G	A	rs121913292|rs121909229		AC-P08-Tumor-SM-63B4X	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P08-Tumor-SM-63B4X	none	g.chr10:89692905G>A	ENST00000371953.3	+	5.0	1746.0	c.389G>A	c.(388-390)cGa>cAa	p.R130Q		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	130.0	Phosphatase tensin-type.		R -> G (loss of phosphatase activity towards Ins(1,3,4,5)P4 and PtdIns(3,4,5)P3).|R -> L (in CD and endometrial hyperplasia; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes).|R -> Q (in CD; loss of phosphatase activity towards Ins(1,3,4,5)P4; retains ability to bind phospholipid membranes).		activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.R130Q(62)|p.0?(37)|p.R130fs*4(13)|p.R130L(12)|p.R130P(7)|p.?(5)|p.R55fs*1(5)|p.K128_R130del(3)|p.Y27fs*1(2)|p.A121_F145del(1)|p.R130fs*2(1)|p.T131fs*50(1)|p.F56fs*2(1)|p.K128fs*47(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771.0		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		GGAAAGGGACGAACTGGTGTA	0.403	R130Q(JHUEM1_ENDOMETRIUM)|R130Q(MDAPCA2B_PROSTATE)|R130Q(MFE296_ENDOMETRIUM)|R130fs*4(AN3CA_ENDOMETRIUM)	31.0	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""			Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)																										yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10.0	10q23.3	5728.0	phosphatase and tensin homolog gene		"""L, E, M, O"""	151.0	Substitution - Missense(81)|Whole gene deletion(37)|Deletion - Frameshift(23)|Unknown(5)|Deletion - In frame(4)|Insertion - Frameshift(1)	endometrium(77)|prostate(18)|central_nervous_system(16)|lung(7)|breast(7)|ovary(7)|skin(6)|haematopoietic_and_lymphoid_tissue(5)|large_intestine(3)|thyroid(2)|soft_tissue(2)|urinary_tract(1)	GRCh37	CM981670|CM991081	PTEN	M	rs121909229						139.0	129.0	133.0					10																	89692905.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	ENST00000371953.3:c.389G>A	10.37:g.89692905G>A	ENSP00000361021:p.Arg130Gln		B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37.0	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	36	5.637233	0.96693	.	.	ENSG00000171862	ENST00000371953	D	0.98345	-4.88	5.22	5.22	0.72569	Phosphatase tensin type (1);Dual specificity phosphatase, catalytic domain (1);	0.000000	0.85682	D	0.000000	D	0.99378	0.9781	H	0.96889	3.9	0.80722	A	1	D	0.89917	1.0	D	0.87578	0.998	D	0.98503	1.0615	8	.	.	.	-1.7685	18.7776	0.91918	0.0:0.0:1.0:0.0	.	130	P60484	PTEN_HUMAN	Q	130	ENSP00000361021:R130Q	.	R	+	2	0	PTEN	89682885	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	9.429000	0.97481	2.411000	0.81874	0.655000	0.94253	CGA	PTEN-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000049241.1	-1.589865	KEEP		+	35.641382	0.08134	17.0	192.0					45.01	8.0	12.0	86.0	133.0	0.4	0.0	0.0	1.0	0.0	0.0	31.04	0.6	1.0	5.35267e-07	6.52712e-07	0.557998	0.0	46.0	8110.0	69.0	86.0	22.0	0.0	0.0	0.0	0.0001915831	0.003	1.0	-6.703595	0.9991646	1.0	1.0	1.0	1.0	0.0	209.0	12.0
FBXW7	0.0	broad.mit.edu	37.0	4	153247289.0	153247289.0	+	Missense_Mutation	SNP	G	G	C	rs149680468		AC-P09-Tumor-SM-63B4Z	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P09-Tumor-SM-63B4Z	none	g.chr4:153247289G>C	ENST00000281708.4	-	10.0	2742.0	c.1513C>G	c.(1513-1515)Cgc>Ggc	p.R505G	FBXW7_ENST00000263981.5_Missense_Mutation_p.R425G|FBXW7_ENST00000603841.1_Missense_Mutation_p.R505G|FBXW7_ENST00000393956.3_Missense_Mutation_p.R329G|FBXW7_ENST00000296555.5_Missense_Mutation_p.R387G|FBXW7_ENST00000603548.1_Missense_Mutation_p.R505G	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	505.0			R -> L (in an ovarian cancer cell line).		interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R505C(60)|p.R505G(18)|p.R425C(14)|p.R266C(13)|p.R425G(9)|p.R266G(9)|p.R387G(6)|p.R387C(3)|p.R505S(3)|p.R387S(1)|p.?(1)|p.R425S(1)|p.R266S(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGAACACAGCGGACTGCTGCA	0.468			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	139.0	Substitution - Missense(138)|Unknown(1)	haematopoietic_and_lymphoid_tissue(44)|large_intestine(26)|endometrium(20)|urinary_tract(15)|lung(15)|upper_aerodigestive_tract(8)|skin(8)|ovary(2)|biliary_tract(1)											167.0	156.0	160.0					4																	153247289.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1513C>G	4.37:g.153247289G>C	ENSP00000281708:p.Arg505Gly		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	17.95	3.513685	0.64522	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.62105	0.05;0.05;0.05;0.05	5.72	4.88	0.63580	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.101576	0.64402	D	0.000001	T	0.78679	0.4321	M	0.75085	2.285	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.81858	-0.0739	10	0.87932	D	0	-12.0024	15.0746	0.72066	0.0681:0.0:0.9319:0.0	.	329;505;387;425	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	G	505;387;425;329	ENSP00000281708:R505G;ENSP00000296555:R387G;ENSP00000263981:R425G;ENSP00000377528:R329G	ENSP00000263981:R425G	R	-	1	0	FBXW7	153466739	1.000000	0.71417	1.000000	0.80357	0.556000	0.35491	9.772000	0.98984	1.559000	0.49555	-0.145000	0.13849	CGC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	103.434937	KEEP		-	105.860342	0.347458	41.0	77.0					50.62	18.0	33.0	42.0	52.0	0.352941	0.0	0.0	1.0	0.0	0.0	29.35	0.647059	0.0	0.0	0.0	0.01441	0.0	47.0	7913.0	163.0	139.0	47.0	25.0	0.0	0.0	0.0006122453	0.003	1.0	-6.656142	0.9405024	1.0	1.0	1.0	1.0	0.0	118.0	16.0
FBXW7	0.0	broad.mit.edu	37.0	4	153247289.0	153247289.0	+	Missense_Mutation	SNP	G	G	C	rs149680468		AC-P09-Tumor-SM-63B52	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P09-Tumor-SM-63B52	none	g.chr4:153247289G>C	ENST00000281708.4	-	10.0	2742.0	c.1513C>G	c.(1513-1515)Cgc>Ggc	p.R505G	FBXW7_ENST00000393956.3_Missense_Mutation_p.R329G|FBXW7_ENST00000296555.5_Missense_Mutation_p.R387G|FBXW7_ENST00000263981.5_Missense_Mutation_p.R425G|FBXW7_ENST00000603841.1_Missense_Mutation_p.R505G|FBXW7_ENST00000603548.1_Missense_Mutation_p.R505G	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	505.0			R -> L (in an ovarian cancer cell line).		interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R505C(60)|p.R505G(18)|p.R425C(14)|p.R266C(13)|p.R425G(9)|p.R266G(9)|p.R387G(6)|p.R387C(3)|p.R505S(3)|p.R387S(1)|p.?(1)|p.R425S(1)|p.R266S(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGAACACAGCGGACTGCTGCA	0.468			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	139.0	Substitution - Missense(138)|Unknown(1)	haematopoietic_and_lymphoid_tissue(44)|large_intestine(26)|endometrium(20)|urinary_tract(15)|lung(15)|upper_aerodigestive_tract(8)|skin(8)|ovary(2)|biliary_tract(1)											167.0	156.0	160.0					4																	153247289.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1513C>G	4.37:g.153247289G>C	ENSP00000281708:p.Arg505Gly		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	17.95	3.513685	0.64522	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.62105	0.05;0.05;0.05;0.05	5.72	4.88	0.63580	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.101576	0.64402	D	0.000001	T	0.78679	0.4321	M	0.75085	2.285	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.81858	-0.0739	10	0.87932	D	0	-12.0024	15.0746	0.72066	0.0681:0.0:0.9319:0.0	.	329;505;387;425	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	G	505;387;425;329	ENSP00000281708:R505G;ENSP00000296555:R387G;ENSP00000263981:R425G;ENSP00000377528:R329G	ENSP00000263981:R425G	R	-	1	0	FBXW7	153466739	1.000000	0.71417	1.000000	0.80357	0.556000	0.35491	9.772000	0.98984	1.559000	0.49555	-0.145000	0.13849	CGC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	136.889564	KEEP		-	138.659274	0.377778	51.0	84.0					53.74	24.0	36.0	48.0	47.0	0.4	0.0	0.0	1.0	0.0	0.0	29.24	0.6	0.0	0.0	0.0	0.01441	0.0	47.0	7913.0	163.0	139.0	47.0	25.0	0.0	0.0	0.000615747	0.003	1.0	-8.659468	0.9477407	1.0	1.0	1.0	1.0	0.0	135.0	16.0
PIK3CA	5290.0	broad.mit.edu	37.0	3	178952074.0	178952074.0	+	Missense_Mutation	SNP	G	G	A	rs121913283		AC-P10-Tumor-SM-63B53	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P10-Tumor-SM-63B53	none	g.chr3:178952074G>A	ENST00000263967.3	+	21.0	3286.0	c.3129G>A	c.(3127-3129)atG>atA	p.M1043I		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	1043.0	PI3K/PI4K.		M -> I (in cancer; shows an increase in lipid kinase activity).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.M1043I(66)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAACAAATGAATGATGCAC	0.368		57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	66.0	Substitution - Missense(66)	large_intestine(36)|endometrium(11)|breast(6)|urinary_tract(4)|lung(4)|cervix(2)|thyroid(1)|central_nervous_system(1)|ovary(1)											98.0	88.0	91.0					3																	178952074.0		1907.0	4120.0	6027.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.3129G>A	3.37:g.178952074G>A	ENSP00000263967:p.Met1043Ile		Q14CW1|Q99762	ENST00000263967.3	37.0	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	15.94	2.979751	0.53827	.	.	ENSG00000121879	ENST00000263967	T	0.75260	-0.92	6.08	6.08	0.98989	Protein kinase-like domain (1);Phosphatidylinositol 3-/4-kinase, catalytic (3);	0.000000	0.85682	D	0.000000	T	0.42944	0.1225	N	0.00500	-1.43	0.80722	D	1	B	0.25955	0.138	B	0.19666	0.026	T	0.58662	-0.7597	10	0.02654	T	1	-20.5202	20.6721	0.99693	0.0:0.0:1.0:0.0	.	1043	P42336	PK3CA_HUMAN	I	1043	ENSP00000263967:M1043I	ENSP00000263967:M1043I	M	+	3	0	PIK3CA	180434768	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.367000	0.97148	2.894000	0.99253	0.591000	0.81541	ATG	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	-10.401177	KEEP		+	7.947213	0.065217	6.0	86.0					40.87	4.0	3.0	44.0	52.0	0.571429	0.0	0.0	1.0	0.0	0.0	30.38	0.428571	1.0	8.12818e-05	9.32525e-05	1.0	0.0	61.0	7944.0	268.0	55.0	4.0	0.0	0.0	0.0	9.470389e-05	0.003	1.0	-4.975036	0.9995632	1.0	1.0	1.0	1.0	0.0	92.0	6.0
FBXW7	0.0	broad.mit.edu	37.0	4	153249385.0	153249385.0	+	Missense_Mutation	SNP	G	G	A			AC-P10-Tumor-SM-63B53	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P10-Tumor-SM-63B53	none	g.chr4:153249385G>A	ENST00000281708.4	-	9.0	2622.0	c.1393C>T	c.(1393-1395)Cgt>Tgt	p.R465C	FBXW7_ENST00000393956.3_Missense_Mutation_p.R289C|FBXW7_ENST00000263981.5_Missense_Mutation_p.R385C|FBXW7_ENST00000603548.1_Missense_Mutation_p.R465C|FBXW7_ENST00000603841.1_Missense_Mutation_p.R465C|FBXW7_ENST00000296555.5_Missense_Mutation_p.R347C	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	465.0			R -> C (in a acute lymphoblastic leukemia cell line).|R -> H (in a colorectal cancer sample; somatic mutation).		interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R465C(71)|p.R226C(11)|p.R385C(11)|p.R347C(3)|p.R465Y(2)|p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGCATACAACGCACAGTGGAA	0.413			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	99.0	Substitution - Missense(98)|Unknown(1)	haematopoietic_and_lymphoid_tissue(41)|large_intestine(27)|endometrium(20)|stomach(6)|biliary_tract(4)|pancreas(1)											260.0	223.0	235.0					4																	153249385.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1393C>T	4.37:g.153249385G>A	ENSP00000281708:p.Arg465Cys		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	28.3	4.909959	0.92107	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.42900	0.96;0.96;0.96;0.96	6.05	6.05	0.98169	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.67287	0.2877	M	0.71206	2.165	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.67130	-0.5748	10	0.87932	D	0	-17.2313	20.6013	0.99457	0.0:0.0:1.0:0.0	.	289;465;347;385	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	C	465;347;385;289	ENSP00000281708:R465C;ENSP00000296555:R347C;ENSP00000263981:R385C;ENSP00000377528:R289C	ENSP00000263981:R385C	R	-	1	0	FBXW7	153468835	1.000000	0.71417	0.959000	0.39883	0.996000	0.88848	9.869000	0.99810	2.878000	0.98634	0.650000	0.86243	CGT	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	325.406366	KEEP		-	325.658974	0.465587	115.0	132.0					40.87	72.0	62.0	80.0	74.0	0.537313	0.0	0.0	1.0	0.0	0.0	30.38	0.462687	1.0	1.90269e-63	3.09148e-63	1.0	0.0	45.0	8089.0	78.0	84.0	36.0	0.0	0.0	0.0	0.0003067147	0.003	1.0	-20.0	0.9998356	1.0	1.0	1.0	1.0	0.0	247.0	117.0
NFE2L2	4780.0	broad.mit.edu	37.0	2	178098810.0	178098810.0	+	Missense_Mutation	SNP	C	C	T			AC-P11-Tumor-SM-63B56	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P11-Tumor-SM-63B56	none	g.chr2:178098810C>T	ENST00000397062.3	-	2.0	789.0	c.235G>A	c.(235-237)Gag>Aag	p.E79K	NFE2L2_ENST00000423513.1_Missense_Mutation_p.E63K|NFE2L2_ENST00000446151.2_Missense_Mutation_p.E63K|NFE2L2_ENST00000464747.1_Missense_Mutation_p.E63K|NFE2L2_ENST00000397063.4_Missense_Mutation_p.E63K	NM_006164.4	NP_006155.2	Q16236	NF2L2_HUMAN	nuclear factor, erythroid 2-like 2	79.0					transcription from RNA polymerase II promoter	centrosome|cytosol|nucleus|plasma membrane	protein dimerization activity|protein domain specific binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity	p.E79K(10)|p.E79Q(10)		central_nervous_system(1)|cervix(4)|endometrium(14)|kidney(5)|large_intestine(4)|liver(13)|lung(71)|oesophagus(29)|skin(2)|upper_aerodigestive_tract(11)|urinary_tract(4)	158.0			Epithelial(96;0.00442)|OV - Ovarian serous cystadenocarcinoma(117;0.00739)|all cancers(119;0.0195)|LUSC - Lung squamous cell carcinoma(2;0.036)|Lung(16;0.0935)			TCACCTGTCTCTTCATCTAGT	0.443			Mis		"""NSCLC, HNSCC"""					HNSCC(56;0.16)																											Dom	yes		2.0	2q31	4780.0	nuclear factor (erythroid-derived 2)-like 2 (NRF2)		E	20.0	Substitution - Missense(20)	lung(13)|oesophagus(4)|upper_aerodigestive_tract(1)|urinary_tract(1)|cervix(1)											147.0	146.0	146.0					2																	178098810.0		1899.0	4107.0	6006.0	SO:0001583	missense			ENSG00000116044	HGNC:7782	NM_006164	Approved	uc002ulh.5	ENST00000397062.3:c.235G>A	2.37:g.178098810C>T	ENSP00000380252:p.Glu79Lys		B2RBU2|Q53RW6|Q59HH2|Q96F71	ENST00000397062.3	37.0	CCDS42782.1	.	.	.	.	.	.	.	.	.	.	C	20.1	3.936470	0.73442	.	.	ENSG00000116044	ENST00000397063;ENST00000397062;ENST00000446151;ENST00000449627;ENST00000448782;ENST00000421929;ENST00000423513	T;T;T;T;T;T;T	0.31769	1.48;1.48;1.48;1.48;1.48;1.48;1.48	5.78	5.78	0.91487	.	0.000000	0.85682	D	0.000000	T	0.64271	0.2583	M	0.87180	2.865	0.80722	D	1	D;D;D;D	0.89917	1.0;0.997;1.0;1.0	D;D;D;D	0.85130	0.996;0.985;0.997;0.996	T	0.68700	-0.5339	10	0.72032	D	0.01	.	19.9976	0.97389	0.0:1.0:0.0:0.0	.	63;63;63;79	E9PGJ7;B4DNB0;C9JFL6;Q16236	.;.;.;NF2L2_HUMAN	K	63;79;63;63;63;63;63	ENSP00000380253:E63K;ENSP00000380252:E79K;ENSP00000411575:E63K;ENSP00000391590:E63K;ENSP00000400073:E63K;ENSP00000412191:E63K;ENSP00000410015:E63K	ENSP00000380252:E79K	E	-	1	0	NFE2L2	177807056	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.298000	0.78815	2.737000	0.93849	0.563000	0.77884	GAG	NFE2L2-001	KNOWN	basic|CCDS	protein_coding		protein_coding	OTTHUMT00000257752.4	317.310229	KEEP		-	320.016514	0.398671	120.0	181.0					62.42	58.0	84.0	106.0	117.0	0.591549	0.0	0.0	1.0	0.0	0.0	27.7	0.408451	1.0	1.24839e-78	1.9981e-78	0.01441	0.0	58.0	8060.0	150.0	54.0	10.0	0.0	0.0	0.0	0.0001267748	0.003	1.0	-20.0	0.9999962	1.0	1.0	1.0	1.0	0.0	301.0	11.0
FBXW7	0.0	broad.mit.edu	37.0	4	153247366.0	153247366.0	+	Missense_Mutation	SNP	C	C	T			AC-P11-Tumor-SM-63B56	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P11-Tumor-SM-63B56	none	g.chr4:153247366C>T	ENST00000281708.4	-	10.0	2665.0	c.1436G>A	c.(1435-1437)cGa>cAa	p.R479Q	FBXW7_ENST00000263981.5_Missense_Mutation_p.R399Q|FBXW7_ENST00000296555.5_Missense_Mutation_p.R361Q|FBXW7_ENST00000393956.3_Missense_Mutation_p.R303Q|FBXW7_ENST00000603841.1_Missense_Mutation_p.R479Q|FBXW7_ENST00000603548.1_Missense_Mutation_p.R479Q	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	479.0					interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R479Q(29)|p.R479L(5)|p.R399Q(3)|p.R479P(2)|p.R240L(1)|p.R361P(1)|p.R399P(1)|p.?(1)|p.R361Q(1)|p.R399L(1)|p.R240Q(1)|p.R240P(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				AGTGGCATCTCGAGAACCGCT	0.403			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4.0	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	47.0	Substitution - Missense(46)|Unknown(1)	haematopoietic_and_lymphoid_tissue(16)|large_intestine(9)|endometrium(7)|urinary_tract(5)|upper_aerodigestive_tract(4)|lung(4)|stomach(1)|kidney(1)											85.0	80.0	82.0					4																	153247366.0		2203.0	4299.0	6502.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1436G>A	4.37:g.153247366C>T	ENSP00000281708:p.Arg479Gln		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	C	33	5.283775	0.95489	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.40756	1.02;1.02;1.02;1.02	5.72	5.72	0.89469	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40 repeat, conserved site (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.50222	0.1603	N	0.12527	0.23	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.56529	-0.7964	10	0.56958	D	0.05	-12.7081	20.2406	0.98372	0.0:1.0:0.0:0.0	.	303;479;361;399	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	Q	479;361;399;303	ENSP00000281708:R479Q;ENSP00000296555:R361Q;ENSP00000263981:R399Q;ENSP00000377528:R303Q	ENSP00000263981:R399Q	R	-	2	0	FBXW7	153466816	1.000000	0.71417	1.000000	0.80357	0.974000	0.67602	7.715000	0.84713	2.857000	0.98124	0.650000	0.86243	CGA	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	124.723118	KEEP		-	124.951778	0.558442	43.0	34.0					62.42	24.0	31.0	15.0	29.0	0.563636	0.0	0.0	1.0	0.0	0.0	27.7	0.436364	1.0	4.44712e-29	6.68963e-29	0.01441	0.0	54.0	7834.0	327.0	98.0	8.0	13.0	0.0	0.0	0.0002935744	0.003	1.0	-14.60746	0.9978628	1.0	1.0	1.0	1.0	0.0	77.0	53.0
EP300	2033.0	broad.mit.edu	37.0	22	41565529.0	41565529.0	+	Missense_Mutation	SNP	G	G	A			AC-P11-Tumor-SM-63B56	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P11-Tumor-SM-63B56	none	g.chr22:41565529G>A	ENST00000263253.7	+	26.0	5414.0	c.4195G>A	c.(4195-4197)Gat>Aat	p.D1399N	RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	1399.0					apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding	p.D1399N(5)|p.D1399Y(2)		NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171.0						ATCTTACCTCGATAGTGTTCA	0.338			"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""				Rubinstein-Taybi syndrome																												Rec	yes		22.0	22q13	2033.0	300 kd E1A-Binding protein gene		"""L, E"""	7.0	Substitution - Missense(7)	lung(3)|upper_aerodigestive_tract(1)|stomach(1)|central_nervous_system(1)|cervix(1)											98.0	93.0	95.0					22																	41565529.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	ENST00000263253.7:c.4195G>A	22.37:g.41565529G>A	ENSP00000263253:p.Asp1399Asn		B1AKC2	ENST00000263253.7	37.0	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	G	29.3	4.998529	0.93227	.	.	ENSG00000100393	ENST00000263253	D	0.99422	-5.88	5.55	5.55	0.83447	.	0.000000	0.46758	D	0.000275	D	0.99743	0.9898	H	0.96633	3.855	0.58432	D	0.999997	D	0.89917	1.0	D	0.91635	0.999	D	0.97288	0.9922	10	0.87932	D	0	-10.979	19.5071	0.95124	0.0:0.0:1.0:0.0	.	1399	Q09472	EP300_HUMAN	N	1399	ENSP00000263253:D1399N	ENSP00000263253:D1399N	D	+	1	0	EP300	39895475	1.000000	0.71417	0.993000	0.49108	0.997000	0.91878	9.760000	0.98935	2.617000	0.88574	0.557000	0.71058	GAT	EP300-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000320600.1	145.783098	KEEP		+	149.460829	0.343195	58.0	111.0					62.42	47.0	29.0	74.0	81.0	0.618421	0.0	0.0	1.0	0.0	0.0	27.7	0.381579	1.0	5.12816e-46	8.04e-46	0.01441	0.0	47.0	7990.0	202.0	81.0	9.0	5.0	0.0	0.0	0.0001757913	0.003	1.0	-8.483261	0.9997296	1.0	1.0	1.0	1.0	0.0	169.0	17.0
MAPK1	5594.0	broad.mit.edu	37.0	22	22127164.0	22127164.0	+	Missense_Mutation	SNP	C	C	T			AC-P11-Tumor-SM-63B56	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P11-Tumor-SM-63B56	none	g.chr22:22127164C>T	ENST00000215832.6	-	7.0	1152.0	c.964G>A	c.(964-966)Gag>Aag	p.E322K	MAPK1_ENST00000398822.3_Missense_Mutation_p.E322K|MAPK1_ENST00000544786.1_Missense_Mutation_p.E278K	NM_002745.4	NP_002736.3	P28482	MK01_HUMAN	mitogen-activated protein kinase 1	322.0					activation of MAPK activity|activation of MAPKK activity|axon guidance|cell cycle|epidermal growth factor receptor signaling pathway|ERK1 and ERK2 cascade|induction of apoptosis|innate immune response|insulin receptor signaling pathway|interspecies interaction between organisms|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|platelet activation|Ras protein signal transduction|regulation of sequence-specific DNA binding transcription factor activity|stress-activated MAPK cascade|synaptic transmission|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription, DNA-dependent	cytosol|nucleoplasm	ATP binding|DNA binding|MAP kinase activity|phosphatase binding|RNA polymerase II carboxy-terminal domain kinase activity	p.E322K(1)		NS(1)|breast(1)|central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(2)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	17.0	Colorectal(54;0.105)	all_lung(157;3.89e-05)		READ - Rectum adenocarcinoma(21;0.0689)	Arsenic trioxide(DB01169)	GCTCTTACCTCGTCACTCGGG	0.478																																														1.0	Substitution - Missense(1)	cervix(1)											165.0	132.0	143.0					22																	22127164.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000100030	HGNC:6871		Approved	uc002zvn.3	ENST00000215832.6:c.964G>A	22.37:g.22127164C>T	ENSP00000215832:p.Glu322Lys			ENST00000215832.6	37.0	CCDS13795.1	.	.	.	.	.	.	.	.	.	.	C	35	5.567659	0.96540	.	.	ENSG00000100030	ENST00000215832;ENST00000415911;ENST00000398822;ENST00000544786	T;T;T	0.46063	0.88;0.88;0.88	4.9	4.9	0.64082	Protein kinase-like domain (1);	0.000000	0.85682	D	0.000000	T	0.79275	0.4418	H	0.98388	4.22	0.80722	D	1	D;D	0.89917	0.999;1.0	P;D	0.83275	0.905;0.996	D	0.87609	0.2502	10	0.87932	D	0	-8.3311	18.6384	0.91386	0.0:1.0:0.0:0.0	.	278;322	A8CZ64;P28482	.;MK01_HUMAN	K	322;310;322;278	ENSP00000215832:E322K;ENSP00000381803:E322K;ENSP00000440842:E278K	ENSP00000215832:E322K	E	-	1	0	MAPK1	20457164	1.000000	0.71417	0.999000	0.59377	0.862000	0.49288	7.564000	0.82326	2.706000	0.92434	0.655000	0.94253	GAG	MAPK1-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000075396.2	22.768929	KEEP		-	27.388053	0.206897	12.0	46.0					62.42	9.0	5.0	25.0	40.0	0.357143	0.0	0.0	1.0	0.0	0.0	27.7	0.642857	1.0	0.000151284	0.000173262	0.001855	0.0	46.0	7787.0	332.0	128.0	27.0	14.0	0.0	0.0	0.0004057761	0.003	1.0	-3.174796	0.9566952	1.0	1.0	1.0	1.0	0.0	58.0	12.0
FBXW7	0.0	broad.mit.edu	37.0	4	153249385.0	153249385.0	+	Missense_Mutation	SNP	G	G	A			AC-P12-Tumor-SM-63B58	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P12-Tumor-SM-63B58	none	g.chr4:153249385G>A	ENST00000281708.4	-	9.0	2622.0	c.1393C>T	c.(1393-1395)Cgt>Tgt	p.R465C	FBXW7_ENST00000296555.5_Missense_Mutation_p.R347C|FBXW7_ENST00000603841.1_Missense_Mutation_p.R465C|FBXW7_ENST00000393956.3_Missense_Mutation_p.R289C|FBXW7_ENST00000263981.5_Missense_Mutation_p.R385C|FBXW7_ENST00000603548.1_Missense_Mutation_p.R465C	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	465.0			R -> C (in a acute lymphoblastic leukemia cell line).|R -> H (in a colorectal cancer sample; somatic mutation).		interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R465C(71)|p.R226C(11)|p.R385C(11)|p.R347C(3)|p.R465Y(2)|p.?(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGCATACAACGCACAGTGGAA	0.413			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	99.0	Substitution - Missense(98)|Unknown(1)	haematopoietic_and_lymphoid_tissue(41)|large_intestine(27)|endometrium(20)|stomach(6)|biliary_tract(4)|pancreas(1)											260.0	223.0	235.0					4																	153249385.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1393C>T	4.37:g.153249385G>A	ENSP00000281708:p.Arg465Cys		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	28.3	4.909959	0.92107	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.42900	0.96;0.96;0.96;0.96	6.05	6.05	0.98169	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.67287	0.2877	M	0.71206	2.165	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.67130	-0.5748	10	0.87932	D	0	-17.2313	20.6013	0.99457	0.0:0.0:1.0:0.0	.	289;465;347;385	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	C	465;347;385;289	ENSP00000281708:R465C;ENSP00000296555:R347C;ENSP00000263981:R385C;ENSP00000377528:R289C	ENSP00000263981:R385C	R	-	1	0	FBXW7	153468835	1.000000	0.71417	0.959000	0.39883	0.996000	0.88848	9.869000	0.99810	2.878000	0.98634	0.650000	0.86243	CGT	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	-0.580693	KEEP		-	34.449094	0.088235	18.0	186.0					46.51	8.0	12.0	122.0	96.0	0.4	0.0	0.0	1.0	0.0	0.0	31.32	0.6	1.0	5.35267e-07	6.35816e-07	0.557998	0.0	45.0	8089.0	78.0	84.0	36.0	0.0	0.0	0.0	0.0002941194	0.003	1.0	-7.151178	0.9964243	1.0	1.0	1.0	1.0	0.0	204.0	117.0
MTOR	2475.0	broad.mit.edu	37.0	1	11187790.0	11187790.0	+	Missense_Mutation	SNP	C	C	A			AC-P12-Tumor-SM-63B59	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P12-Tumor-SM-63B59	none	g.chr1:11187790C>A	ENST00000361445.4	-	44.0	6183.0	c.6107G>T	c.(6106-6108)cGt>cTt	p.R2036L	MTOR_ENST00000376838.1_Missense_Mutation_p.R241L	NM_004958.3	NP_004949.1	P42345	MTOR_HUMAN	mechanistic target of rapamycin (serine/threonine kinase)	2036.0					cell growth|cellular response to hypoxia|insulin receptor signaling pathway|nerve growth factor receptor signaling pathway|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|protein autophosphorylation|protein catabolic process|response to amino acid stimulus|response to nutrient|T cell costimulation|TOR signaling cascade	endoplasmic reticulum membrane|Golgi membrane|lysosome|mitochondrial outer membrane|phosphatidylinositol 3-kinase complex|PML body|TORC1 complex|TORC2 complex	ATP binding|phosphoprotein binding|protein serine/threonine kinase activity			breast(5)|central_nervous_system(7)|endometrium(20)|kidney(34)|large_intestine(21)|lung(43)|ovary(9)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	149.0						AAAGTACAAACGAGATGCCTC	0.542																																														0.0													224.0	231.0	228.0					1																	11187790.0		2203.0	4300.0	6503.0	SO:0001583	missense			ENSG00000198793	HGNC:3942	NM_004958	Approved	uc001asd.3	ENST00000361445.4:c.6107G>T	1.37:g.11187790C>A	ENSP00000354558:p.Arg2036Leu		Q4LE76|Q5TER1|Q6LE87|Q96QG3|Q9Y4I3	ENST00000361445.4	37.0	CCDS127.1	.	.	.	.	.	.	.	.	.	.	C	35	5.422592	0.96111	.	.	ENSG00000198793	ENST00000361445;ENST00000376838	T;T	0.11821	2.93;2.74	5.8	5.8	0.92144	FKBP12-rapamycin-associated protein, FKBP12-rapamycin-binding (3);	0.000000	0.85682	D	0.000000	T	0.51719	0.1691	M	0.93678	3.445	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	T	0.63373	-0.6652	10	0.87932	D	0	-9.885	20.063	0.97692	0.0:1.0:0.0:0.0	.	2036	P42345	MTOR_HUMAN	L	2036;241	ENSP00000354558:R2036L;ENSP00000366034:R241L	ENSP00000354558:R2036L	R	-	2	0	MTOR	11110377	1.000000	0.71417	0.996000	0.52242	0.968000	0.65278	7.456000	0.80751	2.735000	0.93741	0.655000	0.94253	CGT	MTOR-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000005558.1	-59.348351	KEEP		-	16.97978	0.034161	11.0	311.0					50.74	10.0	4.0	198.0	204.0	0.285714	9.05144e-12	9.60423e-12	1.0	1.0	0.0	29.73	0.714286	0.0	0.0	0.0	0.016723	0.0	47.0	8242.0	28.0	4.0	13.0	0.0	0.0	0.0	9.994152e-05	0.003	1.0	-3.381292	1.0	1.0	1.0	1.0	1.0	0.0	322.0	0.0
FBXW7	0.0	broad.mit.edu	37.0	4	153247289.0	153247289.0	+	Missense_Mutation	SNP	G	G	C	rs149680468		AC-P12-Tumor-SM-63B59	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P12-Tumor-SM-63B59	none	g.chr4:153247289G>C	ENST00000281708.4	-	10.0	2742.0	c.1513C>G	c.(1513-1515)Cgc>Ggc	p.R505G	FBXW7_ENST00000603841.1_Missense_Mutation_p.R505G|FBXW7_ENST00000296555.5_Missense_Mutation_p.R387G|FBXW7_ENST00000263981.5_Missense_Mutation_p.R425G|FBXW7_ENST00000603548.1_Missense_Mutation_p.R505G|FBXW7_ENST00000393956.3_Missense_Mutation_p.R329G	NM_033632.3	NP_361014.1	Q969H0	FBXW7_HUMAN	F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase	505.0			R -> L (in an ovarian cancer cell line).		interspecies interaction between organisms|lipid homeostasis|negative regulation of DNA endoreduplication|negative regulation of hepatocyte proliferation|negative regulation of Notch signaling pathway|negative regulation of triglyceride biosynthetic process|positive regulation of epidermal growth factor receptor activity|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|protein stabilization|protein ubiquitination|regulation of lipid storage|regulation of protein localization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|sister chromatid cohesion|vasculature development	nucleolus|nucleoplasm|SCF ubiquitin ligase complex	protein binding	p.R505C(60)|p.R505G(18)|p.R425C(14)|p.R266C(13)|p.R425G(9)|p.R266G(9)|p.R387G(6)|p.R387C(3)|p.R505S(3)|p.R387S(1)|p.?(1)|p.R425S(1)|p.R266S(1)		NS(1)|biliary_tract(8)|bone(1)|breast(5)|central_nervous_system(6)|cervix(2)|endometrium(36)|haematopoietic_and_lymphoid_tissue(159)|kidney(6)|large_intestine(155)|lung(31)|ovary(10)|pancreas(3)|prostate(2)|skin(6)|stomach(16)|upper_aerodigestive_tract(9)|urinary_tract(6)	462.0	all_hematologic(180;0.093)	Acute lymphoblastic leukemia(8;0.000629)|all_hematologic(8;0.067)				TGAACACAGCGGACTGCTGCA	0.468			"""Mis, N, D, F"""		"""colorectal, endometrial, T-ALL"""																																Rec	yes		4	4q31.3	55294.0	"""F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)"""		"""E, L"""	139.0	Substitution - Missense(138)|Unknown(1)	haematopoietic_and_lymphoid_tissue(44)|large_intestine(26)|endometrium(20)|urinary_tract(15)|lung(15)|upper_aerodigestive_tract(8)|skin(8)|ovary(2)|biliary_tract(1)											167.0	156.0	160.0					4																	153247289.0		2203.0	4300.0	6503.0	SO:0001583	missense				HGNC:16712		Approved	uc003ims.3	ENST00000281708.4:c.1513C>G	4.37:g.153247289G>C	ENSP00000281708:p.Arg505Gly		B7ZLP9|Q68DR0|Q96A16|Q96LE0|Q96RI2|Q9NUX6	ENST00000281708.4	37.0	CCDS3777.1	.	.	.	.	.	.	.	.	.	.	G	17.95	3.513685	0.64522	.	.	ENSG00000109670	ENST00000281708;ENST00000296555;ENST00000263981;ENST00000393956	T;T;T;T	0.62105	0.05;0.05;0.05;0.05	5.72	4.88	0.63580	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.101576	0.64402	D	0.000001	T	0.78679	0.4321	M	0.75085	2.285	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;1.0;1.0;1.0	T	0.81858	-0.0739	10	0.87932	D	0	-12.0024	15.0746	0.72066	0.0681:0.0:0.9319:0.0	.	329;505;387;425	B7Z2C8;Q969H0;Q969H0-4;Q969H0-2	.;FBXW7_HUMAN;.;.	G	505;387;425;329	ENSP00000281708:R505G;ENSP00000296555:R387G;ENSP00000263981:R425G;ENSP00000377528:R329G	ENSP00000263981:R425G	R	-	1	0	FBXW7	153466739	1.000000	0.71417	1.000000	0.80357	0.556000	0.35491	9.772000	0.98984	1.559000	0.49555	-0.145000	0.13849	CGC	FBXW7-001	KNOWN	basic|appris_principal|CCDS	protein_coding		protein_coding	OTTHUMT00000469956.1	67.945013	KEEP		-	81.707227	0.202381	34.0	134.0					50.74	18.0	20.0	67.0	87.0	0.473684	0.0	0.0	1.0	0.0	0.0	29.73	0.526316	0.0	0.0	0.0	0.064281	0.0	47.0	7913.0	163.0	139.0	47.0	25.0	0.0	0.0	0.0005968027	0.003	1.0	-2.880277	0.86527	1.0	1.0	1.0	1.0	0.0	168.0	16.0
KRAS	3845.0	broad.mit.edu	37.0	12	25398284.0	25398284.0	+	Missense_Mutation	SNP	C	C	G	rs121913529		AC-P15-Tumor-SM-63B5D	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P15-Tumor-SM-63B5D	none	g.chr12:25398284C>G	ENST00000311936.3	-	2.0	226.0	c.35G>C	c.(34-36)gGt>gCt	p.G12A	KRAS_ENST00000556131.1_Missense_Mutation_p.G12A|KRAS_ENST00000256078.4_Missense_Mutation_p.G12A|KRAS_ENST00000557334.1_Missense_Mutation_p.G12A	NM_004985.3	NP_004976.2	P01116	RASK_HUMAN	Kirsten rat sarcoma viral oncogene homolog	12.0			G -> A (in a colorectal cancer sample; somatic mutation).|G -> C (in lung carcinoma; somatic mutation).|G -> D (in pancreatic carcinoma, GASC and lung carcinoma; somatic mutation).|G -> R (in lung cancer and bladder cancer; somatic mutation).|G -> S (in lung carcinoma and GASC; somatic mutation).|G -> V (in lung carcinoma, pancreatic carcinoma, colon cancer and GASC; somatic mutation).		activation of MAPKK activity|axon guidance|blood coagulation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|Ras protein signal transduction	plasma membrane	GTP binding|GTPase activity|protein binding	p.G12D(8562)|p.G12V(5775)|p.G12A(1407)|p.G12F(46)|p.G12L(8)|p.G12I(4)|p.G12E(3)|p.G12W(3)|p.G12Y(2)|p.G12fs*3(1)|p.G12C(1)|p.G12N(1)	UBE2L3/KRAS(2)	NS(6)|adrenal_gland(1)|autonomic_ganglia(3)|biliary_tract(532)|bone(2)|breast(32)|central_nervous_system(14)|cervix(50)|endometrium(411)|eye(4)|gastrointestinal_tract_(site_indeterminate)(7)|genital_tract(1)|haematopoietic_and_lymphoid_tissue(385)|kidney(8)|large_intestine(15267)|liver(29)|lung(3407)|oesophagus(16)|ovary(612)|pancreas(3739)|penis(1)|peritoneum(6)|prostate(96)|salivary_gland(6)|skin(45)|small_intestine(68)|soft_tissue(88)|stomach(207)|testis(17)|thymus(5)|thyroid(159)|upper_aerodigestive_tract(68)|urinary_tract(57)	25349.0	all_cancers(2;1e-35)|all_epithelial(2;1.97e-38)|all_lung(3;2.1e-23)|Lung NSC(3;1.16e-22)|Acute lymphoblastic leukemia(6;0.00231)|all_hematologic(7;0.00259)|Melanoma(3;0.0301)|Colorectal(261;0.11)|Ovarian(17;0.12)		OV - Ovarian serous cystadenocarcinoma(3;1.23e-21)|Epithelial(3;1.31e-20)|all cancers(3;5.45e-18)|STAD - Stomach adenocarcinoma(2;2.68e-05)			GCCTACGCCACCAGCTCCAAC	0.348	G12A(KMS28BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G12A(KPNSI9S_AUTONOMIC_GANGLIA)|G12A(MM1S_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G12A(NCIH1573_LUNG)|G12A(NCIH2009_LUNG)|G12A(RERFLCAD1_LUNG)|G12A(RPMI8226_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G12A(SW1116_LARGE_INTESTINE)|G12D(AGS_STOMACH)|G12D(ASPC1_PANCREAS)|G12D(COLO678_LARGE_INTESTINE)|G12D(HEC1A_ENDOMETRIUM)|G12D(HEC50B_ENDOMETRIUM)|G12D(HEYA8_OVARY)|G12D(HPAC_PANCREAS)|G12D(HPAFII_PANCREAS)|G12D(KARPAS620_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G12D(KOPN8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|G12D(KP4_PANCREAS)|G12D(L33_PANCREAS)|G12D(LS180_LARGE_INTESTINE)|G12D(LS513_LARGE_INTESTINE)|G12D(MCAS_OVARY)|G12D(PANC0203_PANCREAS)|G12D(PANC0403_PANCREAS)|G12D(PANC0504_PANCREAS)|G12D(PANC0813_PANCREAS)|G12D(PANC1_PANCREAS)|G12D(PK1_PANCREAS)|G12D(PK59_PANCREAS)|G12D(SKLU1_LUNG)|G12D(SNUC2A_LARGE_INTESTINE)|G12D(SU8686_PANCREAS)|G12D(SUIT2_PANCREAS)|G12D(SW1990_PANCREAS)|G12V(A498_KIDNEY)|G12V(CAPAN2_PANCREAS)|G12V(CFPAC1_PANCREAS)|G12V(COLO668_LUNG)|G12V(CORL23_LUNG)|G12V(DANG_PANCREAS)|G12V(HCC56_LARGE_INTESTINE)|G12V(HUPT4_PANCREAS)|G12V(KP3_PANCREAS)|G12V(LCLC97TM1_LUNG)|G12V(NCIH2444_LUNG)|G12V(NCIH441_LUNG)|G12V(NCIH727_LUNG)|G12V(PANC0327_PANCREAS)|G12V(PATU8902_PANCREAS)|G12V(PATU8988S_PANCREAS)|G12V(QGP1_PANCREAS)|G12V(RCM1_LARGE_INTESTINE)|G12V(RERFLCAD2_LUNG)|G12V(RKN_OVARY)|G12V(SH10TC_STOMACH)|G12V(SHP77_LUNG)|G12V(SNGM_ENDOMETRIUM)|G12V(SW403_LARGE_INTESTINE)|G12V(SW480_LARGE_INTESTINE)|G12V(SW620_LARGE_INTESTINE)|G12V(SW900_LUNG)|G12V(YAPC_PANCREAS)	119.0	Mis		"""pancreatic, colorectal, lung, thyroid, AML, others"""				Noonan syndrome;Cardiofaciocutaneous syndrome	TSP Lung(1;<1E-08)|Multiple Myeloma(2;<1E-6)																									Pancreas(8;6 143 191 305 2070 2426 4376 10944 11745 26467 38091 50869)		Dom	yes		12.0	12p12.1	3845.0	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog		"""L, E, M, O"""	15813.0	Substitution - Missense(15812)|Deletion - Frameshift(1)	large_intestine(9453)|pancreas(3002)|lung(1512)|ovary(500)|biliary_tract(369)|endometrium(319)|haematopoietic_and_lymphoid_tissue(163)|stomach(124)|prostate(59)|thyroid(55)|small_intestine(43)|upper_aerodigestive_tract(30)|urinary_tract(30)|soft_tissue(28)|skin(27)|cervix(22)|liver(16)|breast(11)|testis(9)|oesophagus(8)|central_nervous_system(7)|peritoneum(5)|kidney(4)|eye(4)|gastrointestinal_tract_(site_indeterminate)(3)|NS(3)|thymus(3)|autonomic_ganglia(2)|salivary_gland(1)|bone(1)											91.0	81.0	85.0					12																	25398284.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome;CFC, CFCS	ENSG00000133703	HGNC:6407	NM_033360	Approved	uc001rgp.1	ENST00000311936.3:c.35G>C	12.37:g.25398284C>G	ENSP00000308495:p.Gly12Ala		A8K8Z5|B0LPF9|P01118|Q96D10	ENST00000311936.3	37.0	CCDS8702.1	.	.	.	.	.	.	.	.	.	.	C	29.3	4.996285	0.93167	.	.	ENSG00000133703	ENST00000311936;ENST00000557334;ENST00000256078;ENST00000556131	T;T;T;T	0.78003	-1.14;-1.14;-1.14;-1.14	5.68	5.68	0.88126	Small GTP-binding protein domain (1);	0.000000	0.85682	D	0.000000	D	0.85643	0.5744	M	0.74546	2.27	0.80722	D	1	P;P	0.52842	0.898;0.956	P;P	0.55303	0.658;0.773	D	0.87064	0.2155	10	0.87932	D	0	.	18.3719	0.90409	0.0:1.0:0.0:0.0	.	12;12	P01116-2;P01116	.;RASK_HUMAN	A	12	ENSP00000308495:G12A;ENSP00000452512:G12A;ENSP00000256078:G12A;ENSP00000451856:G12A	ENSP00000256078:G12A	G	-	2	0	KRAS	25289551	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.743000	0.85020	2.668000	0.90789	0.563000	0.77884	GGT	KRAS-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000412230.1	973.368393	KEEP		-	974.154352	0.463873	321.0	371.0					38.08	202.0	222.0	233.0	269.0	0.523585	0.0	0.0	1.0	0.0	0.0	27.9	0.476415	0.0	0.0	0.0	0.01441	0.0	81.0	8120.0	93.0	34.0	4.0	0.0	0.0	0.0	6.440977e-05	0.003	1.0	-20.0	1.0	1.0	1.0	1.0	1.0	0.0	692.0	5.0
KRAS	3845.0	broad.mit.edu	37.0	12	25398262.0	25398262.0	+	Missense_Mutation	SNP	C	C	G	rs121913538		AC-P15-Tumor-SM-63B5F	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-P15-Tumor-SM-63B5F	none	g.chr12:25398262C>G	ENST00000311936.3	-	2.0	248.0	c.57G>C	c.(55-57)ttG>ttC	p.L19F	KRAS_ENST00000556131.1_Missense_Mutation_p.L19F|KRAS_ENST00000256078.4_Missense_Mutation_p.L19F|KRAS_ENST00000557334.1_Missense_Mutation_p.L19F	NM_004985.3	NP_004976.2	P01116	RASK_HUMAN	Kirsten rat sarcoma viral oncogene homolog	19.0					activation of MAPKK activity|axon guidance|blood coagulation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|Ras protein signal transduction	plasma membrane	GTP binding|GTPase activity|protein binding	p.L19F(15)	UBE2L3/KRAS(2)	NS(6)|adrenal_gland(1)|autonomic_ganglia(3)|biliary_tract(532)|bone(2)|breast(32)|central_nervous_system(14)|cervix(50)|endometrium(411)|eye(4)|gastrointestinal_tract_(site_indeterminate)(7)|genital_tract(1)|haematopoietic_and_lymphoid_tissue(385)|kidney(8)|large_intestine(15267)|liver(29)|lung(3407)|oesophagus(16)|ovary(612)|pancreas(3739)|penis(1)|peritoneum(6)|prostate(96)|salivary_gland(6)|skin(45)|small_intestine(68)|soft_tissue(88)|stomach(207)|testis(17)|thymus(5)|thyroid(159)|upper_aerodigestive_tract(68)|urinary_tract(57)	25349.0	all_cancers(2;1e-35)|all_epithelial(2;1.97e-38)|all_lung(3;2.1e-23)|Lung NSC(3;1.16e-22)|Acute lymphoblastic leukemia(6;0.00231)|all_hematologic(7;0.00259)|Melanoma(3;0.0301)|Colorectal(261;0.11)|Ovarian(17;0.12)		OV - Ovarian serous cystadenocarcinoma(3;1.23e-21)|Epithelial(3;1.31e-20)|all cancers(3;5.45e-18)|STAD - Stomach adenocarcinoma(2;2.68e-05)			GCTGTATCGTCAAGGCACTCT	0.358		119.0	Mis		"""pancreatic, colorectal, lung, thyroid, AML, others"""				Noonan syndrome;Cardiofaciocutaneous syndrome	TSP Lung(1;<1E-08)|Multiple Myeloma(2;<1E-6)																									Pancreas(8;6 143 191 305 2070 2426 4376 10944 11745 26467 38091 50869)		Dom	yes		12.0	12p12.1	3845.0	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog		"""L, E, M, O"""	15.0	Substitution - Missense(15)	large_intestine(10)|haematopoietic_and_lymphoid_tissue(5)											89.0	78.0	82.0					12																	25398262.0		2203.0	4300.0	6503.0	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome;CFC, CFCS	ENSG00000133703	HGNC:6407	NM_033360	Approved	uc001rgp.1	ENST00000311936.3:c.57G>C	12.37:g.25398262C>G	ENSP00000308495:p.Leu19Phe		A8K8Z5|B0LPF9|P01118|Q96D10	ENST00000311936.3	37.0	CCDS8702.1	.	.	.	.	.	.	.	.	.	.	C	19.99	3.929038	0.73327	.	.	ENSG00000133703	ENST00000311936;ENST00000557334;ENST00000256078;ENST00000556131	D;T;T;T	0.86562	-2.14;-1.3;-1.3;-1.3	5.68	5.68	0.88126	Small GTP-binding protein domain (1);	0.000000	0.85682	D	0.000000	D	0.94364	0.8188	M	0.89840	3.065	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.998;0.999	D	0.94992	0.8135	10	0.87932	D	0	.	14.0395	0.64665	0.0:0.8488:0.1512:0.0	.	19;19	P01116-2;P01116	.;RASK_HUMAN	F	19	ENSP00000308495:L19F;ENSP00000452512:L19F;ENSP00000256078:L19F;ENSP00000451856:L19F	ENSP00000256078:L19F	L	-	3	2	KRAS	25289529	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	1.986000	0.40677	2.668000	0.90789	0.563000	0.77884	TTG	KRAS-001	KNOWN	basic|appris_candidate|CCDS	protein_coding		protein_coding	OTTHUMT00000412230.1	-123.731782	KEEP		-	195.27143	0.058824	92.0	1472.0					46.52	33.0	35.0	457.0	472.0	0.514706	0.0	0.0	1.0	0.0	0.0	31.24	0.485294	0.0	0.0	0.0	1.0	0.0	84.0	8052.0	156.0	41.0	0.0	0.0	0.0	0.0	4.010971e-05	0.003	1.0	-20.0	0.9999961	1.0	1.0	1.0	1.0	0.0	1564.0	9.0
PIK3CA	5290.0	broad.mit.edu	37.0	3	178936091.0	178936091.0	+	Missense_Mutation	SNP	G	G	A	rs104886003		AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	AC-DFCI_AC_PD1-1-Tumor-SM-9LRI9	none	g.chr3:178936091G>A	ENST00000263967.3	+	10.0	1790.0	c.1633G>A	c.(1633-1635)Gag>Aag	p.E545K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	545.0	PI3K helical.		E -> A (in cancer).|E -> G (in KERSEB).|E -> K (in KERSEB; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N-terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation; enhances invadopodia-mediated extracellular matrix degradation and invasion in breast cancer cells).		epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity	p.E545K(881)|p.E545Q(18)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269.0	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			TGAAATCACTGAGCAGGAGAA	0.353	E545K(BC3C_URINARY_TRACT)|E545K(BFTC909_KIDNEY)|E545K(DLD1_LARGE_INTESTINE)|E545K(ESS1_ENDOMETRIUM)|E545K(HCC202_BREAST)|E545K(HCT15_LARGE_INTESTINE)|E545K(HSC4_UPPER_AERODIGESTIVE_TRACT)|E545K(HT1197_URINARY_TRACT)|E545K(HUH28_BILIARY_TRACT)|E545K(KYSE510_OESOPHAGUS)|E545K(L363_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|E545K(MCF7_BREAST)|E545K(MDAMB361_BREAST)|E545K(MKN1_STOMACH)|E545K(NCIH460_LUNG)|E545K(NCIH508_LARGE_INTESTINE)|E545K(NCIH596_LUNG)|E545K(RERFLCSQ1_LUNG)|E545K(TCCSUP_URINARY_TRACT)|E545K(TE5_OESOPHAGUS)	57.0	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																									Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290.0	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	899.0	Substitution - Missense(899)	breast(308)|large_intestine(286)|urinary_tract(97)|lung(44)|endometrium(37)|ovary(25)|stomach(17)|upper_aerodigestive_tract(16)|skin(14)|central_nervous_system(13)|cervix(13)|thyroid(7)|oesophagus(7)|penis(4)|kidney(3)|soft_tissue(2)|pancreas(2)|haematopoietic_and_lymphoid_tissue(1)|biliary_tract(1)|NS(1)|pituitary(1)											61.0	60.0	60.0					3																	178936091.0		1813.0	4072.0	5885.0	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	ENST00000263967.3:c.1633G>A	3.37:g.178936091G>A	ENSP00000263967:p.Glu545Lys		Q14CW1|Q99762	ENST00000263967.3	37.0	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	36	5.703347	0.96812	.	.	ENSG00000121879	ENST00000263967	T	0.63255	-0.03	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.73822	0.3636	L	0.51914	1.62	0.80722	D	1	D	0.62365	0.991	D	0.62955	0.909	T	0.68872	-0.5294	10	0.32370	T	0.25	-25.7963	20.0024	0.97423	0.0:0.0:1.0:0.0	.	545	P42336	PK3CA_HUMAN	K	545	ENSP00000263967:E545K	ENSP00000263967:E545K	E	+	1	0	PIK3CA	180418785	1.000000	0.71417	1.000000	0.80357	0.951000	0.60555	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAG	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding		protein_coding	OTTHUMT00000348409.2	-15.934107	KEEP		+	53.455062	0.07672	29.0	349.0					35.39	20.0	16.0	187.0	248.0	0.555556	0.0	0.0	1.0	0.0	0.0	36.69	0.444444	1.0	4.3181e-19	5.85745e-19	1.0	0.0	104.0	7897.0	243.0	62.0	13.0	14.0	0.0	0.0	0.0002587665	0.003	1.0	-2.774621	0.9607525	1.0	1.0	1.0	1.0	0.0	378.0	470.0
